An encouraging news report about an experimental drug being developed by Gilead Sciences Inc. for Covid-19 led shares of the drugmaker to jump nearly 8% in trading Friday and helped to spur gains in the total market.
A doctor in Chicago told colleagues that Gilead’s drug remdesivir appeared to help many patients enrolled in a clinical trial site at the University of Chicago Medicine hospital, according to a news report in online health publication STAT, which cited a video of the remarks. The doctor said that the hospital...
SecAFOfficial WaldorfNYC
Who volunteers for the control group?
At least you can learn that nobody DIES from the drug.
What's impt is they had started a trial for the efficacy of the drug and new sampling designs for patient participants can be done for wider trials and more conclusive comparative analysis.
Well any news is good news, at the worst it atleast shows efficacy in some people; Heard from other MD’s in other states too telling it seems to work; let’s hope for the best and end to this fear
It would be great if COVID19 related articles were made available to nonsubscriber.
1,000 beyond numbers or words
At least it is a start. Now a broader study can be done. Work quickly please.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: MarketWatch - 🏆 3. / 97 Read more »
Source: MarketWatch - 🏆 3. / 97 Read more »